Kate Travis

Why has it taken more than a year to correct a COVID-19 paper?

A correction to a clinical trial on a potential treatment for COVID-19 has taken more than a year — and counting — to get published. In the meantime, the article remains marked with an expression of concern that appeared in February 2024.

The Lancet Regional Health–Americas published the study, a randomized clinical trial of the effect of metformin on hospitalization rates among COVID-19 patients, in December 2021. It has been cited 36 times, according to Clarivate’s Web of Science, 12 of those since the publication of the expression of concern.

In December 2023, the authors “identified small errors in the statistical analysis primary outcome,” corresponding author Edward Mills, a health research methods professor at McMaster University, in Hamilton, Ontario, told Retraction Watch. “We immediately re-ran the analysis and submitted as an erratum,” he said.

Experiment using AI-generated posts on Reddit draws fire for ethics concerns

Note: We’ve published a new story with the University of Zurich’s response, as well as comments from Reddit’s chief legal officer.

An experiment deploying AI-generated messages on a Reddit subforum has drawn criticism for, among other critiques, a lack of informed consent from unknowing participants in the community.

The university overseeing the research is standing by its approval of the study, but has indicated the principal investigator has received a warning for the project.

The subreddit, r/ChangeMyView (CMV), invites people to post a viewpoint or opinion to invite conversation from different perspectives. Its extensive rules are intended to keep discussions civil.

A new journal record: Sage title retracts 678 more papers, tally over 1,500

The retraction of “a final batch” of 678 articles concludes Sage’s investigation into questionable peer review, citation manipulation, and other signs of paper mill activity at one of its journals, according to the publisher.

Sage has been investigating the Journal of Intelligent and Fuzzy Systems (JIFS) since early 2024 for “indicators that raised concerns about the authenticity of the research and the peer review process underlying these articles,” a Sage spokesperson told us. We reported in August on Sage’s retraction of 467 articles from the journal. The publisher retracted another 416 papers in January. With this latest batch, “our investigation into JIFS is now concluded,” the spokesperson said.

Sage acquired JIFS in November 2023 when it bought IOS Press. The indexing company Clarivate raised concerns about the quality of the articles in the journal shortly after and put the journal’s indexing on hold. Its entry on the Clarivate website still shows the “on hold” flag.

Chinese funding agency sanctions 26 researchers in latest misconduct report

The organization responsible for allocating basic research funding in China has issued misconduct findings against 26 researchers for violations ranging from breach of confidentiality to image manipulation, plagiarism, and buying and selling authorship.

The National Natural Science Foundation of China, or NSFC, released the results of 15 misconduct investigations on April 11. Several of the investigations involved teams of researchers and many included specific published papers, 53 in total. China has been taking steps to crack down on academic fraud, calling last year for a review of all retracted articles in English- and Chinese-language journals.

Penalties for the researchers ranged from bans on applying for funding or serving as a reviewer, to having research funding revoked — which includes having to return funds already dispersed. In most cases, the restrictions on applying for funding were for three to seven years.

Indian university’s channel on publisher’s platform disappears

Screenshot of Saveetha University’s Cureus channel from February 6, 2025

The Saveetha Institute of Medical and Technical Sciences in India has been on our radar for a while. So when we got word the university’s channel on an open access journal platform disappeared, we were curious what might be going on.

Just this year, we reported Saveetha was among 14 universities with “questionable publication practices,” defined as unusually fast growth in research output, as measured by published journal articles.

Our 2023 investigation into Saveetha’s dental school uncovered an elaborate self-citation scheme: Undergraduates write manuscripts as part of their exams; student and faculty reviewers then insert scores of citations to papers by Saveetha faculty to inflate the university’s citation rankings.

Former VA physician admitted to altering images and deleting data, documents show

A former cancer specialist sanctioned for “recklessly falsifying data” admitted during an investigation interview that he periodically altered images, documents obtained by Retraction Watch show. He also stated “he may have inadequately or improperly labeled and organized” image files, increasing the chances the images were confused or misidentified.

Alan Lichtenstein, previously a staff physician at the Veterans Affairs Greater Los Angeles Healthcare System and faculty member at UCLA, engaged in research misconduct, according to a November 2024 notice in the Federal Register. Documents we obtained through a public records request revealed his admissions, made during an inquiry that preceded the misconduct ruling.

The documents also reveal a relatively swift process: The initial inquiry by a joint UCLA-VA GLA committee took from June to August 2023 to determine a full investigation should follow. The investigation committee, formally tasked in October of that year, finished its assessment in March 2024. The inquiry committee looked at 18 allegations across 12 papers, and the investigation considered 31 allegations in 13 papers.

Why RFK Jr.’s pick for a vaccine-autism review may be familiar to Retraction Watch readers

David Geier and his father Mark speak to Fox News in 2022.

When it comes to conversations about vaccines and autism, we always have plenty to write about. And the latest news that the Trump administration has tapped David Geier for a study on possible links between immunizations and autism, first reported by the Washington Post, is no exception.

Geier has a long history of promoting the debunked claim of a link between vaccines and autism, STAT and others report. He has published on the topic as recently as 2020. A December 2020 paper lists his affiliation as the Institute of Chronic Illnesses, an organization he founded with his father Mark Geier, court documents say. In 2011, the Maryland State Board of Physicians disciplined Geier for practicing medicine without a license. He’s currently listed in the HHS employee directory as a senior data analyst, the Post reports.

Geier’s first appearance in Retraction Watch was in 2017, when Science and Engineering Ethics, a Springer Nature title, retracted a paper on how conflicts of interest might influence research on the link between vaccines and autism. That paper has been cited 13 times according to Clarivate’s Web of Science.

Kidney researcher debarred from federal U.S. funding for image manipulation

A former Baylor College of Medicine researcher has been debarred from federal funding for two years after a review by the Office of Research Integrity found evidence of misconduct.

Liping Zhang, a former assistant professor in the school’s nephrology section, “engaged in research misconduct in research supported by U.S. Public Health Service (PHS) funds,” according to a notice scheduled for publication in the Federal Register on March 19.

ORI based its findings on a Baylor College of Medicine investigation as well as evidence gathered during its oversight review, the notice states. It continues:

Food scientist impersonated as an editor and reviewer in Frontiers articles

Frontiers has issued a retraction and multiple corrections for papers in several of its journals after the publisher discovered a reviewer had been impersonated.

Alla El-Din Bekhit is listed as the editor of the retracted article, a study of the potential anti-cancer effects of asparagus extract published in Frontiers in Pharmacology in May 2023. According to the retraction notice, dated January 26, the article contained duplicated images and “concerns were raised regarding scientific validity of the article.” The notice continues:

Further, the investigation confirmed that a non-genuine email address was used to impersonate Alaa El-Din Bekhit and the real Alaa El-Din Bekhit did not take any actions on this manuscript.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: